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Abstract
Over the centuries the idea of recurrent fevers has 
mainly been associated with malaria, but many other 
fevers, such as typhoid and diphtheria were cause for 
concern. It is only in recent times, with the more severe 
forms of fever from infectious origin becoming less 
frequent or a cause for worry that we started noticing 
recurrent fevers without any clear infectious cause, 
being described as having a pathogenesis of autoinflam-
matory nature. The use of molecular examinations in 
many cases can allow a diagnosis where the cause is 
monogenic. In other cases, however the pathogenesis is 
likely to be multifactorial and the diagnostic-therapeutic 
approach is strictly clinical. The old fever tree paradigm 
developed to describe fevers caused by malaria has 
been revisited here to describe today’s periodic fevers 
from the periodic fever adenitis pharyngitis aphthae 
syndrome to the more rare autoinflammatory diseases. 
This model may allow us to place cases that are yet 
to be identified which are likely to be of multifactorial 
origin.
Key words:  Recurrent fevers; Malaria; Autoinflammatory 
diseases; Periodic fever adenitis pharyngytis aphthe 
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Core tip: Periodic fevers of autoinflammatory nature 
have been increasingly recognized in recent decades, 
in many cases reflecting monogenic disorders of infla-
mmation. However, patients can be encountered in 
clinical practice who don’t fit in any definite category of 
periodic fever, despite of extensive molecular analyses. 
A clinical approach based on the analogy with the well 
defined monogenic diseases can be reasonable in these 
cases, which likely represent an heterogeneous group 
of multifactorial disorders. We propose revising the 
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historical image of the fever tree to figure the possible 
existence of a disease continuum between multifactorial 
and monogenic periodic fever syndromes. 
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THE CONCEPT OF FEVER: FROM FEBRILE 
ILLNESS TO HYPERSENSITIVITY
Fever has been considered for a long time as a primary 
illness in itself rather than a physiologic process 
occurring with disorders of various origin, marked by a 
raised body temperature mostly of infectious nature. In 
spite of this, since antiquity, some physicians believed 
that the high temperatures during a febrile illness could 
have some beneficial effects, being followed usually 
by a spell of sweating and subsequent resolution[1]. 
The idea of fever as “a mighty engine which Nature 
brings into the world for the conquest of her enemies” 
was promoted by Thomas Sydenham, even though 
he was unsuspecting that fever occurs as the result of 
immune activation caused by such “enemies” usually 
represented by bacteria or viruses[2]. 
In recent centuries, following the urbanization and 
the overcrowding of cities, fevers caused by epide­
mics such as diphtheria, flue, smallpox, measles and 
pertussis became a serious concern in most areas of 
the World, being accountable for a high death rate 
in early childhood. These epidemiological changes 
probably conditioned the notion of fever, which started 
to be considered a harmful reaction to infections by the 
body. Thus, antipyretics were initially introduced rather 
as an attempt to cure the fever instead of relieving 
sufferers from their discomfort. In actual fact, enhanced 
microbiological knowledge didn’t immediately result in 
downgrading the importance of febrile temperature vis­
à­vis to the infection itself, until the beginning of the 
twentieth century when a new concept emerges which 
considers fever as a manifestation of immune activation 
to exogenous agents[3]. At the same time, on the other 
hand, it was becoming apparent that hyperthermia 
or fever could be beneficial in supporting the healing 
process following various diseases such as gonorrhea 
and syphilis[4]. 
Although the mortality rate caused by infectious 
febrile illnesses dramatically decreased in western 
countries around the mid XX century, the fear of fever, 
or “fever phobia” quoting a term coined by Schmitt[5] 
in 1980, persisted within folklore beliefs to some 
extent until today. Moreover, it has been argued that 
the unrealistic concerns about fever sprung from the 
patient’s and the caregiver’s misconceptions concerning 
what constitutes a high temperature[1,6,7]. It may be 
worth recalling that as far back as 1871 Wunderlich, 
after collecting data on one million measurements 
of body temperature, established 37.0 ℃ (range 
36.2­37.5) as the normal human body temperature, 
suggesting that temperatures above 38.0 ℃ had to be 
considered “suspicious” of febrile nature[8].
RECURRENT FEVERS: FROM MALARIA 
TO AUTOINFLAMMATORY PERIODIC 
FEVERS
Flares of fever recurring with a repetitive clinical picture 
characterize recurrent fevers, suggesting that they are 
brought about by a single and persistent cause[9,10]. 
In ancient civilizations, fever caused by malaria and 
typhoid was probably among the febrile illnesses of 
major concern. Indeed, medical historicists are still 
debating whether Alexander the Great died of malaria or 
typhoid fever[11]. Especially malaria has been for many 
centuries the most common and alarming recurrent 
fever among people living around the Mediterranean 
Sea. Ancient Romans celebrated the Etruscan divinity 
Februs with a purification ritual on the month of Fe­
bruary. The celebration was later dedicated to the 
divinity febris (fever), protector from recurrent seasonal 
fevers due to malaria. This is where the Valentine Day 
celebration probably later originated from, maybe in 
reference to “love fever”. Malaria was so rooted in the 
Italian wetlands that people venerated the Virgin Mary 
of fevers to seek for protection (Figure 1)[12]. 
In 1712, a few decades after quinine had become 
available to cure the disease, the Italian physician 
Torti[13] proposed a classification of febrile illnesses based 
on the response to quinine, which was represented in 
his famous figure of the fever tree (Figure 2). The fever 
tree was not only about malaria, but it covered all types 
of fever known at that time. Regardless of the real 
utility of a classification based on apparent response to 
quinine, this figure reflected the concept of fever as a 
leading feature of diseases. 
During the first decades of the XX century, er­
adication of malaria from most Western countries, 
together with improved socioeconomic conditions and 
the availability of vaccines and drugs for many infectious 
diseases, contributed to a dramatic reduction in the 
mortality rates caused by febrile illnesses. At the same 
time, the development of laboratory diagnostics and 
the observation of ex juvantibus’ response to antibiotics 
allowed the identification, in many cases, of the fever’s 
infectious cause. It is not surprising that only in this 
scenario was the recurrence of fevers beginning to be 
noticed in some individuals without a putative infectious 
cause. Indeed, only after the Second World War did 
physicians start describing subjects with seemingly 
unprovoked episodes of fever, simultaneously recurring 
with a set of various other complaints, usually on the 
skin, in the joints, muscles, abdomen, chest and lymph 
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nodes (Figure 3). 
It was quite clear that such recurrent fevers were 
the result of a pathologic immune mechanism, but the 
term “autoinflammatory” was only proposed at the end 
of the century to describe the particular pathogenesis of 
these disorders[14]. The pivotal role of Interleukin 1 (IL­1) 
in the pathogenesis of autoinflammatory disorders 
(ADs) was highlighted both in experimental studies as 
well as in therapeutic trials with IL­1 blocking agents[15]. 
This change in knowledge was of particular importance, 
as a proper identification of this category of disorders 
could allow better diagnostic and therapeutic choices, 
avoiding useless examinations and treatments such as 
antibiotics[16]. Moreover, the conception of fever was 
changing once again, from beneficial in most infections, 
to harmful when becoming the expression of immune 
dysregulation. Actually, it is not fever in itself that is 
harmful, but IL-1 related inflammation. 
The first AD described was familial Mediterranean 
fever (FMF) called by the name of “benign paroxysmal 
peritonitis”. Clinically, FMF is characterized by recurrent 
and self­limited attacks of fever lasting 12­72 h with 
peritonitis, pleurisy, arthritis or erysipelas­like skin 
disease and a marked acute­phase response. Subse­
quent complications of untreated patients are due to 
renal amyloidosis. The temperature may reach 38­40 ℃ 
and can anticipate other symptoms, although some 
patients may only have a fever. Diagnosis of FMF is 
primarily clinical and based on the use of the diagnostic 
criteria[17­19].
After FMF, a number of other monogenic AD’s are 
described, presenting recurrent fever together with 
several other combinations of clinical features (Figure 3). 
Actually, there is a great heterogeneity among AD’s 
concerning prevalence, severity and clinical features. 
On one end of the spectrum one finds the rare and 
often severe disorders due to mutations in a number 
of inflammasome­related genes, as is the case for 
Cryopyrinopathies, DIRA, DITRA and others, and on the 
opposite end there is the periodic fever adenitis phar­
yngitis aphthae syndrome (PFAPA). This is a relatively 
common disorder with likely multifactorial pathogenesis, 
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Figure 1  The Virgin Mary of Fevers, by Nicola Mellini, XIX century, 
Bologna, Italy.
Figure 2  The fever tree, Francesco Torti (image from the Comenius Project, 
http://89.97.218.226/web1/pontina/biologia/p_37.htm)[10].
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Figure 3  Timeline discovery periodic fevers autoinflammatory disease. PFAPA: Periodic fever adenitis pharyngitis aphthae; DITRA: Deficiency or interleukin-36-
receptor antagonist deficiency; DIRA: Deficiency of interleukin-1–receptor antagonist; PAPA: Pyogenic arthritis, pyoderma gangrenosum, and acne. 
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varying high risk of developing amyloidosis[26].
NOVEL CONCEPTS AND THE FEVER 
TREE REVISITED
In the last decade, some evidences have been ac­
cumulated demonstrating a poor correlation between 
phenotype and genotype in AD. Environmental factors 
can modify the clinical presentation, as in the case of 
FMF. This was elegantly demonstrated by the evidence 
represented by the people with FMF who immigrated to 
Germany and in spite of similar genetic backgrounds, 
tended to present milder symptoms compared with 
their cousins who remained in Turkey[27]. In addition, 
although it is well known that FMF is transmitted with 
autosomal recessive inheritance, in certain families 
some mutations can be associated with a dominant 
inheritance, this has lead to the belief that there are 
other possible contributions in the pathology stemming 
from other genetic and environmental factors. 
Indeed, patients with heterozygous mutation or with 
multiple low penetrance variants in the MEFV gene may 
display attenuated phenotypes resembling more PFAPA 
than FMF, making it difficult to definitely confirm the 
diagnosis of FMF[28].
A similar behavior is also described when talking 
about other periodic fever syndromes, such as TRAPS. 
Some genetic variants for example, relatively common 
in the general population, may have low penetrance 
occurring mostly in healthy people, that can also be 
associated, in some individuals, with a typical manifes­
tation of the disease[29]. In fact, the correlation between 
genotype and phenotype in patients with AD is often 
incomplete and many patients could receive the wrong 
diagnoses such as inflammatory bowel disease, Behçet 
disease or adult onset Still disease, being excluded from 
genetic testing for AD[16,30]. 
In addition, a number of recent reports showed that 
it could be relatively common, even following extensive 
molecular analysis, to find subjects with periodic fever 
lacking a definite genetic diagnosis[31­34]. In some cases 
genetic variants of uncertain significance in AD-related 
genes may be found, yet their relevance for diagnosis 
is currently unpredictable[35,36]. Recently, evidence­
based provisional clinical classification criteria for autoin-
flammatory periodic fevers have been proposed, which 
may help diagnosing patients with uncertain genetic 
results[37]. In addition, these criteria can be used to 
classify patients with undifferentiated diseases based 
on the similarity of their clinical pictures with the known 
hereditary periodic fever syndromes. 
To represent this complexity, we proposed revisiting 
the ancient figure of the fever tree (Figure 4). 
The figure of the tree can serve to represent AD as 
a disease continuum, from the common multifactorial 
PFAPA syndrome, which is figured by the trunk, to the 
rare monogenic diseases, represented by the tip of 
the branches. Going from the trunk to the major limbs 
usually characterized by mild symptoms and a benign 
course[20]. It is worth noting that, although it is the most 
common among autoinflammatory periodic fevers, 
PFAPA has been described relatively late, in 1989. This 
delay may be related to concerns raised during the 
previous two centuries about rheumatic fever, in addition 
to the higher incidence of other serious febrile illnesses 
of infectious origin. Indeed, in the first decades of the 
XX century, Rheumatic Fever, usually occurring as a 
sequel of Group A Streptococcus (GAS) tonsillitis, was 
still a prominent health problem in developed countries, 
being associated with the high risk of carditis. In some 
subjects GAS tonsillitis could recur, increasing the risk 
of developing chronic hearth injury. In fact, almost 
one third of children underwent early tonsillectomy 
in the years before the Second World War and we 
cannot know how many of them could have had PFAPA 
syndrome rather than GAS tonsillitis. More often than 
not tonsillectomy was performed as prevention in 
subjects who had never developed tonsillitis. Actually, 
during the past century, Western countries witnessed a 
progressive decline in the incidence of rheumatic fever, 
mostly irrespective of the availability of antibiotics and 
to the practice of tonsillectomy[21]. Nevertheless, fear of 
Rheumatic Fever persisted for decades and might have 
been in part responsible for the delayed identification of 
PFAPA[22]. 
Half way between PFAPA and rare monogenic AD, 
there is a group of well characterized hereditary periodic 
fevers that can show up with a higher frequency in 
certain populations, as FMF in Mediterranean people, 
mevalonate kinase deficiency (MKD) in Dutch and tumor 
necrosis factor associated periodic fever (TRAPS) in 
people with Northern European ancestry[23]. Patients with 
MKD present fever episodes lasting 3 to 7 d that typically 
recur every 4 to 6 wk. The fever may be accompanied 
by lymphadenopathy, abdominal pain with diarrhea or 
vomiting, headache, polyarthralgia or arthritis of large 
joints, skin lesions such as papular, urticarial, nodular 
or purpuric rash. Patients with TRAPS show attacks of 
extremely variable duration and intensity (from 1­2 d to 
3­4 wk), characterized by fever accompanied more or 
less constantly by sterile peritonitis with abdominal pain, 
diarrhea or constipation, nausea, and vomiting. Mono­ 
or bilateral periorbital edema is a very characteristic 
and almost pathognomonic sign of the disease, often 
associated with conjunctivitis and periorbital pain. 
Also very frequent are arthralgias, muscle cramps, 
centrifugally spreading migratory myalgias, chronic 
fasciitis, serpiginous rash, consisting of migratory and 
painful patches[24,25].
Besides a few exceptions, a common feature of 
periodic fever syndromes is the reversibility of symptoms 
with a complete sense of wellbeing outside the flares, 
lacking the development of sustained autoimmunity 
and progressive inflammatory damage. Exceptions are 
severe ADs which tend to present a continuous course 
rather than a periodic one as well as specific syndromes 
such as FMF and TRAPS which, if not treated, present a 
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and then up to the top of the smaller branches, we 
can find a number of intermediate phenotypes, which 
might be underpinned by a variety of genetic variants 
in the same genes, which have evolved towards more 
severe forms, or other genes altogether which are yet 
to be identified. For example, low penetrance mutations 
in the genes responsible for FMF, TRAPS and MKD 
have been associated with PFAPA­like phenotype[28,29]. 
Indeed, MKD encompasses a wide range of phenotypes, 
from the most severe end, represented by mevalonic 
aciduria which we can figure on the tip of the branch, to 
MKD and Hyper-IgD syndrome, which in milder cases 
can closely resemble PFAPA[38].
PFAPA itself may not be actually considered as 
a single disease, but rather as a heterogeneous syn­
drome. Atypical cases have been described, and can 
currently be encountered. Typically, patients with PFAPA 
present episodes of tonsillopharyngitis accompanied 
by enlarged neck lymph nodes and mouth aphthae: 
the periodic recurrence of fever episodes, the response 
to a single administration of low dose glucocorticoids, 
and the conclusive healing after tonsillectomy are all 
characteristic features of the disease. However, it is not 
uncommon to encounter patients with periodic fever 
and tonsillitis who present atypical signs, such as a 
poor response to glucocorticoids, a recurrence following 
tonsillectomy or the presence of significant cutaneous, 
articular or abdominal symptoms, in addition to ph­
aryngeal involvement. In a small proportion of these 
atypical PFAPA cases, a definite diagnosis of hereditary 
periodic fever can be done (e.g., MKD or TRAPS), while 
in most cases the analysis of a more or less complete 
set of genes associated with HPF can only reveal 
the presence of common genetic variants of vague 
significance or no variants at all. Few cases in this 
group may still be due to yet unidentified monogenic 
disorders or to somatic mosaicism for mutations in 
autoinflammatory genes, similarly to what has been 
described for subjects with cryopirin associated periodic 
syndromes or Blau sindrome[39,40]. In most cases, 
however, it is reasonable to assume that this group is 
composed by patients with true multifactorial disorders 
with intermediate characteristics between PFAPA and 
various types of autoinflammatory diseases. In this 
regard, it is worth noting that some patients with 
atypical PFAPA may respond to colchicine, in analogy 
with FMF. Operatively, we could represent the disease of 
such patients on the fever tree positioned between the 
PFAPA trunk and the bottom of the FMF branch.
This picture doesn’t claim to be complete but can 
help to be confronted with an expanding spectrum of 
AD’s, including patients with atypical presentations 
lacking a definite genetic diagnosis. Further studies are 
needed to understand the role of genetic and environ­
mental factors in these cases. Moreover, it remains to 
be evaluated whether a practical approach based on the 
clinical analogies with well defined AD’s can represent a 
reasonable choice in these cases.
In fact, so far, we can identify only a few groups of 
diseases based on the response to treatments and in 
particular if there is a preferential response to low dose 
glucocorticoids, colchicines or cytokine inhibitors (IL­1 or 
TNF­α).
It may be worth recording that, in regards to autoin­
flammatory diseases, fever in itself, is never the harm. 
Treatments should be aimed at relieving patients from 
pain and discomfort and, in some diseases in preventing 
long-term damage from chronic inflammation.
This review may tell just a part of the story and 
represent a simplification of the field. However, as 
physicians, we still need to be able to cure, understand, 
and act expediently in daily practice when dealing with 
the disease, without necessarily knowing the genetic 
makeup of each individual patient with his or her indivi­
dual variability, manifestation and diseases development, 
keeping in mind that the personalization of medicine is 
not just genetically driven. 
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